Laura G. E.
- Country
- Spain
- Department
- Oncology
Research Overview
- Evaluation of GDC-9545 Monotherapy and Combination Therapy with Palbociclib and/or LHRH Agonist in Locally Advanced or Metastatic ER-Positive Breast Cancer
- Phase II Study on Maintenance Therapy with Trastuzumab and Pertuzumab Post-Trastuzumab Deruxtecan in HER2-Positive Unresectable Metastatic Breast Cancer
- Efficacy and Safety of Olaparib as Adjuvant Therapy in Germline BRCA1/2 Mutated High-Risk HER2-Negative Primary Breast Cancer: A Phase III Randomized Study
Data & Insights
Has run more than one trial at 163 of 339 partner sites.
Specializations
Breast Cancer Specialization
This investigator focuses extensively on various subtypes of breast cancer, particularly advanced and metastatic cases. Their research encompasses hormone receptor-positive (HR+), HER2-positive, and triple-negative breast cancer (TNBC) variants.
- Metastatic Disease Management
- Early-Stage Breast Cancer
- Locally Advanced Disease
Special attention is given to novel therapeutic approaches for treating aggressive forms of breast cancer.
Targeted Therapy Expertise
The investigator specializes in evaluating innovative targeted treatments, including antibody-drug conjugates and hormone therapy combinations. Their work involves studying responses to various therapeutic agents in different breast cancer subtypes.
- Endocrine Therapy
- HER2-Targeted Treatments
- CDK4/6 Inhibitors
Research focuses on personalized treatment approaches based on specific molecular markers.
Immunotherapy Research
The investigator explores immunotherapeutic approaches in breast cancer treatment, particularly studying PD-L1 expression and its implications for treatment selection. Their work includes evaluation of combination therapies with immune checkpoint inhibitors.
- PD-L1 Testing
- Combination Immunotherapy
- Biomarker Analysis
Focus includes identification of optimal patient populations for immunotherapy treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.